Prathik Krishnan

Dr. Prathik Krishnan


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2014 in International Journal of Angiology
Verified
Journal Article
Closed access
PDF file
PKPrathik Krishnan
Prathik Krishnan
PRPoornima Ramadas
Poornima Ramadas
PRPrejith P. Rajendran
Prejith P. Rajendran
PMParvathy Madhavan
Parvathy Madhavan
AAAsha Alex
Asha Alex
MBMadhu Bhaskaran
Madhu Bhaskaran
Parvovirus B19 (PVB19) is a DNA virus which causes clinically relevant infection in renal transplant recipients (RTR) leading to significant morbidity. Manifestations include erythropoietin resistant anemia, proteinuria, and glomerulosclerosis in the allograft. Severe infection may require administration of intravenous immunoglobulin, reduction in immunosuppression and transfusions. The major challenge in managing and preventing the infection in RTR involves the act of balancing the decreased level of immunosuppression and the risk of rejection. The objective of this article is to understand the importance of PVB19 infection and its outcome in RTR. We reviewed the medical records of three RTR with confirmed PVB19 infection and recorded patient information including demographics, clinical and laboratory data, management, and outcome. The average time of occurrence of PVB19 infection as transplant was 8.6 weeks and they presented with symptomatic anemia. Elevated creatinine values were noted in two of them. Following treatment, anemia improved and creatinine values returned to baseline. One of them developed an early relapse and had to be treated once again similarly. We emphasize the importance of maintaining a high index of suspicion for PVB19 infection in patients with anemia in the posttransplant phase, especially in patients on higher doses of immunosuppressants. Early and proper treatment can prevent worsening clinical condition and possible effects on the allograft.

17 March 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PRPoornima Ramadas
Poornima Ramadas
PRPrejith P. Rajendran
Prejith P. Rajendran
PKPrathik Krishnan
Prathik Krishnan
AAAsha Alex
Asha Alex
ESEric Siskind
Eric Siskind
EMErnesto P. Molmenti
Ernesto P. Molmenti
Urinary tract infection (UTI) is a well-recognized early complication in renal transplant recipients (RTR) and can have significant bearing on their outcome. The recent rise in incidence of extended spectrum beta lactamase (ESBL) producing bacteria causing UTI among RTR poses new and significant challenges in terms of management and outcome. Our aim is to analyze the effect of ESBL producing bacteria causing UTI in these patients and its impact on allograft function. We reviewed the medical records of 147 RTR who were followed at a tertiary care hospital affiliated transplant center between January 2007 and May 2013 and noted five RTR who developed episodes of ESBL producing bacteria related UTI during follow up. Multiple patient characteristics including demographics, immunosuppression, recurrences, allograft function and outcome were analyzed. Five patients (3.4%) out of 147 had ESBL producing bacteria related UTI. We found all patients to be above 60 years of age, with three out of five being females, and all five patients had diabetes mellitus. We identified a total of 37 episodes of UTI among these five patients during this period. Two of these patients had elevated creatinine values during the episodes of UTI and three of them developed bacteremia. Of the five patients, four of them had a favorable outcome except for one patient who developed persistent allograft dysfunction. RTR are at a higher risk for developing ESBL producing bacteria associated UTI. Early diagnosis along with appropriate and judicious use of antibiotics will ensure long term success in allograft and patient outcome.

8 July 2019 in Cureus
Verified
Journal Article
Open access
PDF file
PKPrathik Krishnan
Prathik Krishnan
PRPoornima Ramadas
Poornima Ramadas
DLDavid Landsberg
David Landsberg
Bariatric surgery is recognized as a highly effective therapy for obesity but it does carry a risk of short term and long term complications since it results in a permanent alteration of the patient's anatomy. We present a case of 45-year-old female presented with a macular rash on extremities and facial rash from a rehabilitation center after having been discharged a month earlier from a revision surgery on her gastric bypass for anastomotic bleeding. She progressively became lethargic with Magnetic Resonance Imaging (MRI) of the brain showed symmetrically restricted diffusion concerning for hypoxic injury. Her ammonia levels were at 142 micromoles per liter (mmol/L) at the initial check which worsened to 432 mmol/L over a few days, despite treatment. Laboratory investigation later revealed her to be deficient in zinc along with many essential and nonessential amino acids. Supplemental nutrition was initiated, specifically fortifying her parenteral feeds with the essential amino acid combinations that were found deficient on testing. This lead to a slow but progressive improvement in encephalopathy. This case highlights the importance of understanding the short and long term complications of bariatric surgery. Although neurological complications are rare with peripheral neuropathy being the most common one, hyperammonemic encephalopathy is a very severe complication, with incompletely understood mechanisms and predispositions, frequently resulting in failure of recognition and subsequent delays in intervention.

1 January 2016 in journal of Cancer Therapeutics and Research
Verified
Journal Article
Open access
PDF file
PRPoornima Ramadas
Poornima Ramadas
PKPrathik Krishnan
Prathik Krishnan
APAakriti Pandita
Aakriti Pandita
MPManju Paul
Manju Paul
CCChristopher Curtiss
Christopher Curtiss
AGAjeet Gajra
Ajeet Gajra
Background: Small cell lung cancer is a neuroendocrine neoplasm representing about 15 percent of all lung cancers. Sarcoidosis is a multisystem granulomatous disease. The involvement of mediastinal lymph nodes

1 May 2018 in American Journal of Therapeutics
Verified
Journal Article
Closed access
PDF file
PRPoornima Ramadas
Poornima Ramadas
PKPrathik Krishnan
Prathik Krishnan
VFVincent Frechette
Vincent Frechette

1 February 2017 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PKPrathik Krishnan
Prathik Krishnan
PRPoornima Ramadas
Poornima Ramadas
RCRumon Chakravarty
Rumon Chakravarty
BSBirendra Sah
Birendra Sah